文献速递肿瘤 PET/CT

PET/CT影像组学特征对接受手术的非小细胞肺癌患者无病生存期的预测

Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-09-24

研究纳入295例接受手术的非小细胞肺癌患者,分析CT与FDG PET图像的纹理特征构建影像组学特征,采用Cox比例风险回归模型预测无病生存期(DFS)。CT、PET、PET+CT影像组学模型的AUC分别为0.75(95%CI:0.65-0.85)、0.68(95%CI:0.57-0.80)、0.68(95%CI:0.58-0.74),加入临床预测因子后AUC分别为0.61(95%CI:0.51-0.69)、0.64(95%CI:0.53-0.75)、0.65(95%CI:0.50-0.72)。结论认为已识别并验证了可预测手术治疗的NSCLC患者DFS的影像组学特征。

要点

  • CT影像组学Cox模型预测DFS的AUC为0.75(95%CI:0.65-0.85)。
  • PET及PET+CT影像组学模型AUC均为0.68(95%CI分别为0.57-0.80和0.58-0.74)。
  • 加入临床参数后各模型AUC为0.61-0.65,均低于纯影像组学模型。

核心结论

  • 已识别并验证了基于CT、PET或PET/CT图像的影像组学特征,可用于预测接受手术的非小细胞肺癌患者的无病生存期。

研究设计与样本

  • 研究纳入295例接受手术的非小细胞肺癌患者,记录年龄、性别、组织学类型、肿瘤分级和分期等临床参数。
  • 分析PET/CT扫描仪生成的CT和氟脱氧葡萄糖PET图像,使用LifeX软件包计算纹理特征,采用R平台进行统计分析。
  • 数据集通过随机选择分为两个队列,用于统计模型的训练和验证,预测因子输入多变量Cox比例风险回归模型,并计算受试者工作特征曲线及曲线下面积。

主要发现

  • 仅含影像组学特征的Cox模型在CT、PET、PET+CT图像的AUC分别为0.75(95%CI:0.65-0.85)、0.68(95%CI:0.57-0.80)、0.68(95%CI:0.58-0.74)。
  • 在Cox模型中加入临床预测因子后,CT、PET、PET+CT图像的AUC分别为0.61(95%CI:0.51-0.69)、0.64(95%CI:0.53-0.75)、0.65(95%CI:0.50-0.72)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radiomic features derived from the texture analysis of different imaging modalities e show promise in lesion characterisation, response prediction, and prognostication in lung cancer patients. The present study aimed to identify an images-based radiomic signature capable of predicting disease-free survival (DFS) in non-small cell lung cancer (NSCLC) patients undergoing surgery. METHODS: A cohort of 295 patients was selected. Clinical parameters (age, sex, histological type, tumour grade, and stage) were recorded for all patients. The endpoint of this study was DFS. Both computed tomography (CT) and fluorodeoxyglucose positron emission tomography (PET) images generated from the PET/CT scanner were analysed. Textural features were calculated using the LifeX package. Statistical analysis was performed using the R platform. The datasets were separated into two cohorts by random selection to perform training and validation of the statistical models. Predictors were fed into a multivariate Cox proportional hazard regression model and the receiver operating characteristic (ROC) curve as well as the corresponding area under the curve (AUC) were computed for each model built. RESULTS: The Cox models that included radiomic features for the CT, the PET, and the PET+CT images resulted in an AUC of 0.75 (95%CI: 0.65-0.85), 0.68 (95%CI: 0.57-0.80), and 0.68 (95%CI: 0.58-0.74), respectively. The addition of clinical predictors to the Cox models resulted in an AUC of 0.61 (95%CI: 0.51-0.69), 0.64 (95%CI: 0.53-0.75), and 0.65 (95%CI: 0.50-0.72) for the CT, the PET, and the PET+CT images, respectively. CONCLUSIONS: A radiomic signature, for either CT, PET, or PET/CT images, has been identified and validated for the prediction of disease-free survival in patients with non-small cell lung cancer treated by surgery.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Kirienko M, Cozzi L, Antunovic L, et al. Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery. Eur J Nucl Med Mol Imaging. 2017. PMID: 28944403. doi:10.1007/s00259-017-3837-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。